Potentiality and Boundaries of Use of Sorafenib in Patients with Hepatocellular Carcinoma: Awaiting the Results of Ongoing Clinical Trials

Author: Di Maio Massimo   Daniele Gennaro   Piccirillo Maria Carmela   Giordano Pasqualina   Signoriello Giuseppe   Daniele Bruno   Perrone Francesco  

Publisher: MDPI

E-ISSN: 2072-6694|4|2|549-565

ISSN: 2072-6694

Source: Cancers, Vol.4, Iss.2, 2012-06, pp. : 549-565

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content